XML 21 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF EQUITY - USD ($)
$ in Thousands
Total
Class A Common Shares
Class B Common Shares
Total Equity
Total Shareholders' Equity
Common Shares
Common Shares
Class A Common Shares
Common Shares
Class B Common Shares
Preferred Shares
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss) Income
Distributions in Excess of Net Income
Noncontrolling Interests
Common Shares
Beginning Balance at Dec. 31, 2019 $ 3,196                        
Increase (Decrease) in Temporary Equity                          
Equity Contribution to Consolidated Joint Venture 21                        
Adjustment to Record Noncontrolling Interest at Redemption Value (3,196)                        
Net Income (Loss) (21)                        
Ending Balance at Dec. 31, 2020 $ 0                        
Beginning Balance at Dec. 31, 2019       $ 871,801 $ 807,619   $ 387 $ 0 $ 147 $ 1,144,808 $ 530 $ (338,253) $ 64,182
Balance at the Beginning (in shares) at Dec. 31, 2019           38,652,650              
Balance at the Beginning (in shares) at Dec. 31, 2019                 14,703,214        
Beginning Balance (in shares) at Dec. 31, 2019                         4,279,946
Increase (Decrease) in Stockholders' Equity                          
Issuance Costs/Other       (137) (137)         (137)      
Unit Conversions (in shares) 0                        
Dividends and Distributions declared:                          
Preferred Shares       (1,007) (1,007)             (1,007)  
Dividend Reinvestment Plan $ 14     14 14         14      
Dividend Reinvestment Plan (in shares)           1,094              
Share Based Compensation:                          
Grants (Forfeitures)       0 0   2     (2)      
Grants (in shares)           189,738             1,112,862
Amortization       9,969 3,106         3,106     $ 6,863
Change in Fair Value of Derivative Instruments (23,842)     (23,842) (21,779)           (21,779)   (2,063)
Adjustment to Record Noncontrolling Interest at Redemption Value       3,196 3,196         3,196      
Net Income (Loss) (187,766)     (187,745) (168,185)             (168,185) (19,560)
Ending Balance at Dec. 31, 2020       672,249 622,827   389 0 $ 147 1,150,985 (21,249) (507,445) $ 49,422
Balance at the Ending (in shares) at Dec. 31, 2020           38,843,482              
Balance at the Ending (in shares) at Dec. 31, 2020                 14,703,214        
Ending Balance (in shares) at Dec. 31, 2020                         5,392,808
Increase (Decrease) in Temporary Equity                          
Equity Contribution to Consolidated Joint Venture 158                        
Adjustment to Record Noncontrolling Interest at Redemption Value 2,310                        
Net Income (Loss) (158)                        
Ending Balance at Dec. 31, 2021 $ 2,310                        
Increase (Decrease) in Stockholders' Equity                          
Unit Conversions       0 3,026   2     3,024     $ (3,026)
Unit Conversions (in shares) 241,545         241,545             (241,545)
Dividends and Distributions declared:                          
Preferred Shares       (48,348) (48,348)             (48,348)  
Dividend Reinvestment Plan $ 0                        
Share Based Compensation:                          
Grants (Forfeitures)       358 358   3     355      
Grants (in shares)           239,998             1,774,990
Amortization       12,688 2,980         2,980     $ 9,708
Change in Fair Value of Derivative Instruments (16,856)     16,856 15,038           15,038   1,818
Adjustment to Record Noncontrolling Interest at Redemption Value       (2,310) (2,310)         (2,310)      
Net Income (Loss) (43,355)     (43,197) (36,521)             (36,521) (6,676)
Ending Balance at Dec. 31, 2021 $ 608,296     608,296 557,050   394 0 $ 147 1,155,034 (6,211) (592,314) $ 51,246
Balance at the Ending (in shares) at Dec. 31, 2021   39,325,025 0     39,325,025              
Balance at the Ending (in shares) at Dec. 31, 2021 14,703,214               14,703,214        
Ending Balance (in shares) at Dec. 31, 2021                         6,926,253
Increase (Decrease) in Temporary Equity                          
Adjustment to Record Noncontrolling Interest at Redemption Value $ 2,766                        
Ending Balance at Dec. 31, 2022 5,076                        
Increase (Decrease) in Stockholders' Equity                          
Issuance Costs/Other       (57) (57)         (57)      
Unit Conversions $ 0       1,376   $ 1     1,375     $ (1,376)
Unit Conversions (in shares) 80,627         180,627             (180,627)
Dividends and Distributions declared:                          
Common Shares       (23,815) (23,815)             (23,815)  
Preferred Shares       (24,174) (24,174)             (24,174)  
Common Units       (1,053)                 $ (1,053)
LTIP Units $ (100)     (3,113)                 (3,113)
Dividend Reinvestment Plan 6     6 6         6      
Dividend Reinvestment Plan (in shares)           847              
Share Based Compensation:                          
Grants (Forfeitures)       (657) (151)         (154)     $ (506)
Grants (in shares)           190,952 3,000           194,427
Amortization       12,347 3,619         3,619     $ 8,728
Change in Fair Value of Derivative Instruments 25,387     25,387 22,424           22,424   2,963
Adjustment to Record Noncontrolling Interest at Redemption Value       (2,766) (2,766)         (2,766)      
Net Income (Loss) 166,060     166,060 149,488             149,488 16,572
Ending Balance at Dec. 31, 2022 $ 756,461     $ 756,461 $ 683,000   $ 398 $ 0 $ 147 $ 1,157,057 $ 16,213 $ (490,815) $ 73,461
Balance at the Ending (in shares) at Dec. 31, 2022   39,697,451 0     39,697,451              
Balance at the Ending (in shares) at Dec. 31, 2022 14,703,214               14,703,214        
Ending Balance (in shares) at Dec. 31, 2022                         6,940,053